McKesson shares rise as Q4 earnings top estimates

Published 08/05/2025, 21:54
McKesson shares rise as Q4 earnings top estimates

NEW YORK - McKesson Corporation (NYSE:MCK) shares gained 2.8% after the healthcare services company reported better-than-expected fourth-quarter earnings and announced plans to separate its Medical-Surgical Solutions segment.

McKesson posted adjusted earnings per share of $10.12 for the quarter ended March 31, 2025, surpassing analyst estimates of $9.81. Revenue came in at $90.82 billion, up 19% YoY but below the consensus forecast of $93.48 billion.

For the full fiscal year 2025, McKesson reported consolidated revenues of $359.1 billion, a 16% increase from the previous year. Adjusted earnings per diluted share rose 20% to $33.05.

The company provided fiscal 2026 adjusted EPS guidance of $36.75 to $37.55, indicating 11% to 14% growth compared to fiscal 2025. The midpoint of $37.15 is slightly above the analyst consensus of $36.83.

"McKesson delivered strong fourth quarter performance reporting revenue growth of 19% and Adjusted Earnings per Diluted Share growth of 64%," said CEO Brian Tyler. "This marks another year of strong financial results, above our long-term targets, underpinned by operational execution against our strategic priorities."

In a significant strategic move, McKesson announced its intention to separate its Medical-Surgical Solutions segment into an independent company. The company believes this separation will enhance strategic opportunities and operational focus for both entities while unlocking shareholder value.

McKesson also updated its long-term adjusted segment operating profit growth target for U.S. Pharmaceutical (TADAWUL:2070) from 5-7% to 6-8%, reflecting confidence in its core business.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.